PPH Legal Blog

A group of Pittsburgh researchers have made an important discovery that will hopefully result in significant health benefits to individuals diagnosed with pulmonary hypertension.
The researchers have discovered that a simple new blood test will allow them to track the progression of the disease far more easily than before.  Pulmonary hypertension has no cure, and currently […]

[Read more →]

A Philadelphia jury gave a defense verdict a few weeks ago in one of the last mass tort cases brought against a diet drug company.
Danny Crowder of Texas brought a lawsuit against Wyeth, which was formerly American Home Products, claiming that his wife’s death was a direct result of diet pills manufactured by this company.
Crowder’s […]

[Read more →]

Researchers at the Columbia University College of Physicians and Surgeons have announced a new breakthrough in the fight to treat primary pulmonary hypertension. A recent study of 405 PPH patients that was headed by Dr. Robyn J. Barst suggests that Cialis (generic name tafalafil) may have uses beyond its intended purpose of treated erectile dysfunction. […]

[Read more →]

The Fen-phen trial, in which three attorneys who represented Fen-phen users are on trial for looting a $200 million settlement, remains undecided after its second day of jury deliberation.  The trio of lawyers has been accused of conspiracy to commit wire fraud.  If found guilty, each defendant faces up to 20 years in prison and […]

[Read more →]

In the final stages of the trial, the lawyer-defendants involved in the Fen-phen trial called an adverse witness, class action guru Stanley Chesley, to testify on their behalf.   This move appears as a last ditch effort for the lawyer-defendants who lack experts willing to testify in their favor.
Chesley testified that he had been hired by […]

[Read more →]